K Lilleby
- Epidemiology top 10%
- Hematology top 5%
- Oncology
- Immunology
- Infectious Diseases
- Co-authors
- Elizabeth ReedJ D MeyersPaula S. DandlikerRaleigh A. BowdenJack W. SingerSandra KurtinCD BucknerF R Appelbaum
- Topics
- Multiple Myeloma Research and Treatments (5 papers)Hematopoietic Stem Cell Transplantation (4 papers)Hematological disorders and diagnostics (2 papers)
- Cited by
- HematologyEpidemiologyOncology
- Partner nations
- United StatesSouth Africa
In The Last Decade
K Lilleby
9 papers receiving 536 citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Epidemiology 344
- Hematology 244
- Oncology 178
- Immunology 99
- Infectious Diseases 78
Countries citing papers authored by K Lilleby
This map shows the geographic impact of K Lilleby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Lilleby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Lilleby more than expected).
Fields of papers citing papers by K Lilleby
This network shows the impact of papers produced by K Lilleby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Lilleby. The network helps show where K Lilleby may publish in the future.
Co-authorship network of co-authors of K Lilleby
This figure shows the co-authorship network connecting the top 25 collaborators of K Lilleby. A scholar is included among the top collaborators of K Lilleby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Lilleby. K Lilleby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 9 | |
| 3 | 5 | |
| 4 | 12 | |
| 5 | Syngeneic marrow transplantation in patients with multiple myeloma. | 43 |
| 6 | High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer. | 30 |
| 7 | Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both. | 18 |
| 8 | Phase I study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failure. | 19 |
| 9 | Treatment of Cytomegalovirus Pneumonia with Ganciclovir and Intravenous Cytomegalovirus Immunoglobulin in Patients with Bone Marrow Transplantsbreakdown → | 412 |
About K Lilleby
K Lilleby is a scholar working on Hematology, Emergency Medicine and Oncology, having authored 9 papers that have together received 572 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Hematological disorders and diagnostics (2 papers). The work is most often cited by research in Hematology (244 citations), Epidemiology (344 citations) and Oncology (178 citations). K Lilleby has collaborated with scholars based in United States and South Africa. Frequent co-authors include Elizabeth Reed, J D Meyers, Paula S. Dandliker, Raleigh A. Bowden, Jack W. Singer, Sandra Kurtin, CD Buckner, F R Appelbaum, Rainer Storb and Paul L. Weiden. Their work appears in journals such as Annals of Internal Medicine, Clinical journal of oncology nursing and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.